U. Jehn

Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups.

Franco Mandelli, Daniela Diverio, Giuseppe Avvisati et al. · PubMed · 1997 · 474 citations

On the value of intensive remission-induction chemotherapy in elderly patients of 65+ years with acute myeloid leukemia: a randomized phase III study of the European Organization for Research and Treatment of Cancer Leukemia Group.

Bob Löwenberg, R Zittoun, H. Kerkhofs et al. · Journal of Clinical Oncology · 1989 · 386 citations

Elderly Patients, Mixed-phenotype Acute Leukemia, Pharmacotherapy +16

Covalently closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell line

Tomas Lindahl, Alice Adams, Gunnar Bjursell et al. · Journal of Molecular Biology · 1976 · 373 citations

Epstein-barr Virus, Natural Sciences, Immunology +7

An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: Diagnosis and therapeutic outcome

David W. Denning, A. Marinus, J. Cohen et al. · Journal of Infection · 1998 · 257 citations

Diagnostic Mycology, Invasive Aspergillosis, Hematology +6

Use of recombinant GM-CSF during and after remission induction chemotherapy in patients aged 61 years and older with acute myeloid leukemia: final report of AML-11, a phase III randomized study of the Leukemia Cooperative Group of European Organisation for the Research and Treatment of Cancer and the Dutch Belgian Hemato-Oncology Cooperative Group.

Bob Löwenberg, Stefan Suciu, E Archimbaud et al. · PubMed · 1997 · 206 citations